Showing 261 - 280 results of 2,138 for search '"Chronic Myeloid Leukemia"', query time: 0.43s Refine Results
  1. 261

    Vogt-Koyanagi-Harada disease like presentation in patients with chronic myeloid leukemia by Saurabh Mistry, S. Sudharshan, Suganeswari Ganesan, Ashraf Banu Akbar, Jyotirmay Biswas

    Published 2018-06-01
    “…Purpose: To report two rare cases of chronic myeloid leukemia (CML) on tyrosine kinase inhibitors presenting as bilateral serous retinal detachment and ocular inflammation, simulating Vogt-Koyanagi-Harada (VKH) disease. …”
    Get full text
    Article
  2. 262
  3. 263

    Evaluation of Imatinib adherence in chronic myeloid leukemia patients in Babylon Province, Iraq by Athmar Kadhim Gatea, Mohammed Ali Al-Jabory, Noor Hasan Baiee

    Published 2023-01-01
    “…Background: Chronic myeloid leukemia is a clonal myeloproliferative neoplasm that results in proliferation, mainly of granulocytic components. …”
    Get full text
    Article
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269

    Effect of Plumbagin on growth inhibition and apoptosis of imatinib-resistant chronic myeloid leukemia by Bui Thi Kim Ly, Hoang Thanh Chi, Quach Ngo Diem Phuong, Ho Bao Thuy Quyen

    Published 2017-08-01
    “…Development of a new inhibitor of BCR-ABL tyrosine kinase is necessary for the treatment of chronic myeloid leukemia (CML) because of increasing resistance and tolerance to Imatinid efforts. …”
    Get full text
    Article
  10. 270
  11. 271
  12. 272

    Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia by M Yaghmaie, S.H Ghaffari, K Alimoghaddam, A Ghavamzadeh, S.A Mousavi, M Irvani, B Bahar, E Bibordi, M Jahani

    Published 2005-09-01
    “…The incidence of one or other rearrangement in chronic myeloid leukemia (CML) patients varies in different reported se-ries. …”
    Get full text
    Article
  13. 273
  14. 274

    Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia by Yaghmaie M., Ghaffari S.H., Alimoghaddam K., Ghavamzadeh A., Mousavi S.A., Irvani M., Bahar B., Bibordi E., Jahani M

    Published 2005-09-01
    “…The incidence of one or other rearrangement in chronic myeloid leukemia (CML) patients varies in different reported se-ries. …”
    Get full text
    Article
  15. 275

    Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia by Aram Bidikian, Hagop Kantarjian, Elias Jabbour, Nicholas J. Short, Keyur Patel, Farhad Ravandi, Koji Sasaki, Ghayas C. Issa

    Published 2022-10-01
    “…Abstract While the clinical impact of mutations in the ABL1 gene on response to therapy in chronic phase chronic myeloid leukemia (CP-CML) is well established, less is known about how other mutations affect prognosis. …”
    Get full text
    Article
  16. 276
  17. 277
  18. 278
  19. 279

    Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia by Malkan Umit Y., Haznedaroglu Ibrahim C.

    Published 2018-12-01
    “…A 68-year-old woman was diagnosed with chronic myeloid leukemia, and IM was started in 2002 with a dose of 400 mg/day. …”
    Get full text
    Article
  20. 280